Clinical pharmacology of moxalactam in patients with malignant disease.

Por Estey, E H, Weaver, S S, Ho, D H, Bodey, G P
Publicado em 1981

The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy

Por Buckley, S A, Othus, M, Estey, E H, Walter, R B
Publicado no Blood Cancer J (2015)

1,25-Dihydroxyvitamin D3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1beta production.

Por Peleg, S, Qiu, H, Reddy, S, Harris, D, Van, Q, Estey, E H, Talpaz, M, Estrov, Z
Publicado em 1997